These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Construction of tissue micro array from prostate needle biopsies using the vertical clustering re-arrangement technique. Fridman E; Daya D; Srigley J; Whelan KF; Lu JP; Pinthus JH Prostate; 2011 Sep; 71(13):1374-81. PubMed ID: 21308718 [TBL] [Abstract][Full Text] [Related]
3. Construction of tissue microarrays from prostate needle biopsy specimens. Jhavar S; Corbishley CM; Dearnaley D; Fisher C; Falconer A; Parker C; Eeles R; Cooper CS Br J Cancer; 2005 Aug; 93(4):478-82. PubMed ID: 16091762 [TBL] [Abstract][Full Text] [Related]
4. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade. Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer detected by methylated gene markers in histopathologically cancer-negative tissues from men with subsequent positive biopsies. Troyer DA; Lucia MS; de Bruïne AP; Mendez-Meza R; Baldewijns MM; Dunscomb N; Van Engeland M; McAskill T; Bierau K; Louwagie J; Bigley JW Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2717-22. PubMed ID: 19755651 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies. Stewart J; Fleshner N; Cole H; Toi A; Sweet J J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427 [TBL] [Abstract][Full Text] [Related]
8. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. Welch HG; Fisher ES; Gottlieb DJ; Barry MJ J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671 [TBL] [Abstract][Full Text] [Related]
9. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653 [TBL] [Abstract][Full Text] [Related]
10. The role of tissue microarrays in prostate cancer biomarker discovery. Datta MW; True LD; Nelson PS; Amin MB Adv Anat Pathol; 2007 Nov; 14(6):408-18. PubMed ID: 18049130 [TBL] [Abstract][Full Text] [Related]
11. High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates. Sajadi KP; Kim T; Terris MK; Brown JA; Lewis RW Urology; 2007 Oct; 70(4):691-5. PubMed ID: 17991539 [TBL] [Abstract][Full Text] [Related]
12. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. Haas GP; Delongchamps NB; Jones RF; Chandan V; Serio AM; Vickers AJ; Jumbelic M; Threatte G; Korets R; Lilja H; de la Roza G J Natl Cancer Inst; 2007 Oct; 99(19):1484-9. PubMed ID: 17895474 [TBL] [Abstract][Full Text] [Related]
13. Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men. Shigemura K; Arakawa S; Yamanaka K; Kataoka N; Yuien K; Fujisawa M Int J Urol; 2007 Oct; 14(10):935-8. PubMed ID: 17880293 [TBL] [Abstract][Full Text] [Related]
14. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy. Villamón-Fort R; Martínez-Jabaloyas JM; Soriano-Sarriá P; Ramos-Soler D; Pastor-Hernández F; Gil-Salom M Urol Int; 2007; 78(4):328-33. PubMed ID: 17495491 [TBL] [Abstract][Full Text] [Related]